You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
研報掘金丨信達證券:首予邁普醫學“買入”評級,公司正處於業績高速增長期

信達證券研報指出,邁普醫學是國內神經外科領域高性能植入醫療器械的領先企業,產品覆蓋開顱手術所需要的關鍵植入醫療器械,該行認爲公司通過不斷豐富產品組合、完善營銷渠道,有望步入成長快車道,其中基石業務人工硬腦(脊)膜補片產品受集採推動,市場覆蓋率有望加速提升,顱頜面修補產品基於PEEK材料的優異性能,有望快速搶佔傳統鈦材料市場,此外,新產品可吸收止血紗、腦膜膠陸續上市,有望爲公司提供持續增長動力。公司正處於業績高速增長期,首次覆蓋,給予“買入”評級。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account